Case T-477/21: Judgment of the General Court of 24 May 2023 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler) (EU trade mark — Invalidity proceedings — Three-dimensional EU trade mark — Shape of an inhaler — Absolute ground for invalidity — Distinctive character acquired through use — Article 51(2) of Regulation (EC) No 40/94 (now Article 59(2) of Regulation (EU) 2017/1001) — Obligation to state reasons — Article 94 of Regulation 2017/1001)